GHO Capital is preparing to bring clinical trial services provider Velocity Clinical Research to market, sources tell Axios. A recent surge in biotech funding will finance increased R&D, increasing demand for clinical trial site management services like VCR’s. Centerview was hired to run the process, which is anticipated to launch in Q2 or Q3, say the sources. VCR generates EBITDA between around $120 million and $160 million, per sources.
Read the full article: GHO Puts Velocity Clinical Research on the Block //
Source: https://www.axios.com/pro/health-tech-deals/2024/03/11/scoop-gho-puts-velocity-clinical-research-on-the-block